Sellas Life Sciences Group, Inc. · NASDAQ:SLS

Anson Funds Management LP reported a 8.30% stake in Sellas Life Sciences Group, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed May 15, 2025

Anson Funds Management LP reported a 8.30% stake in Sellas Life Sciences Group, Inc., 7,579,095 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
8.30%
Shares
7,579,095
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Anson Funds Management LP8.30%7,579,095
Anson Management GP LLC8.30%7,579,095
Tony Moore8.30%7,579,095
Anson Advisors Inc.8.30%7,579,095
Amin Nathoo8.30%7,579,095
Moez Kassam8.30%7,579,095

Source

View original at SEC

Related